Skip to content

Drug interactions

Duvelisib + Nimodipine

Severity: Major

Duvelisib and Nimodipine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Duvelisib inhibits CYP3A4 and can raise nimodipine levels, increasing the risk of hypotension, flushing, headache and edema. Nimodipine is highly dependent on CYP3A4 for first-pass metabolism, so the effect may be marked.

What this interaction means in plain words

Duvelisib and Nimodipine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Duvelisib belongs to Oncology; Nimodipine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Duvelisib inhibits CYP3A4, decreasing nimodipine first-pass and systemic metabolism.

What to do

Monitor blood pressure closely and consider reducing the nimodipine dose, for example by splitting it into smaller more frequent doses.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duvelisib and Nimodipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Duvelisib with Nimodipine?

MediHelp rates the interaction as major. Duvelisib and Nimodipine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Duvelisib inhibits CYP3A4 and can raise nimodipine levels, increasing the risk of hypotension, flushing, headache and edema. Nimodipine is highly dependent on CYP3A4 for first-pass metabolism, so the effect may be marked.

How serious is the interaction between Duvelisib and Nimodipine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure closely and consider reducing the nimodipine dose, for example by splitting it into smaller more frequent doses.

What other medicines interact with Nimodipine?

MediHelp also lists interactions of Nimodipine with, for example, Apalutamide, Carbamazepine, Ceritinib. The full list is on the Nimodipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in